Startup profile for Precision Epigenomics: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Precision Epigenomics funding, valuation and investors

Epigenomic liquid-biopsy diagnostics for cancer detection and monitoring.

Keep track of Precision Epigenomics

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Not publicly disclosed

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

seed · Tucson, AZ

Source links not recorded Last verified: 2026-07-26

Overview

Precision Epigenomics develops epigenomic liquid-biopsy tests intended to detect and monitor cancer from blood-based epigenetic biomarkers. Based in Tucson, Arizona, the company sits at the intersection of UA life-science commercialization and clinical diagnostics.

Why Precision Epigenomics is interesting

Tucson/UA-adjacent molecular diagnostics play — epigenomic signals in blood as a multi-cancer detection wedge versus mutation-only liquid biopsy approaches.

Product & use cases

Laboratory diagnostics analyzing epigenetic biomarkers in blood for oncology applications.

  • Multi-cancer early detection research/clinical use cases
  • Therapy monitoring
  • Minimal residual disease research contexts

Key facts

  • Tucson epigenomic liquid-biopsy diagnostics
  • Focus: cancer detection/monitoring from blood
  • Website: precision-epigenomics.com

Competitive landscape

Edge: Epigenomic biomarker strategy differentiated from mutation-centric liquid biopsy panels.

  • Grail / Galleri adjacent

    Multi-cancer early detection via methylation — larger commercial scale.

  • Guardant / Exact Sciences adjacent

    Broader liquid-biopsy and screening franchises.

Industries

Biotech & Life Sciences Healthtech

FAQs about Precision Epigenomics

Practical answers founders, operators, and investors typically search for.

Epigenomic liquid-biopsy diagnostics for cancer.
Tucson, Arizona.
Early-stage private diagnostics company.
See status/stage fields on this profile; confirm latest filings for public companies.
Epigenomic liquid-biopsy diagnostics for cancer.
Use whyInteresting, highlights, and linked investors/industries on this page — do not treat directory coverage as a complete cap table.
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.